Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$90,627,000
-$56,541,000 QoQ
Shares Held
850,000
-5.6% QoQ
Ownership
0.389%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#50
of 665 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. INSM ranks #12 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in INSM
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,627,000 | 850,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $147,168,000 | 900,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $52,212,000 | 300,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $180,372,957 | 1,252,503 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $287,775,249 | 2,859,452 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $262,967,357 | 3,446,944 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $113,747,680 | 1,647,562 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $75,377,026 | 1,032,562 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $88,775,000 | 1,325,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,782,500 | 250,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $18,594,000 | 600,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,150,000 | 600,000 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $10,231,500 | 475,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,325,980 | 371,500 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||